Immunotherapy of Cancer: Towards a New Era
In the past two decades, immunotherapy of cancer has developed into an established treatment option. At first, the development of monoclonal antibodies – targeting overexpressed cell surface molecules on tumour cells – resulted in improved survival when combined with standard chemotherapy or radioth...
Main Author: | John B.A.G. Haanen |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2014-11-01
|
Series: | European Medical Journal Oncology |
Subjects: | |
Online Access: | http://emjreviews.com/wp-content/uploads/Immunotherapy-of-Cancer-Towards-a-New-Era.pdf |
Similar Items
-
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
by: María Florencia Mercogliano, et al.
Published: (2021-02-01) -
Talkin’ Toxins: From Coley’s to Modern Cancer Immunotherapy
by: Robert D. Carlson, et al.
Published: (2020-04-01) -
The Evolution of Cancer Immunotherapy
by: Meshaal Khan, et al.
Published: (2021-06-01) -
Immunotherapies for the Treatment of Uveal Melanoma—History and Future
by: Timo E. Schank, et al.
Published: (2019-07-01) -
Current status of cancer immunotherapy
by: Kono K
Published: (2014-04-01)